Page 8 - Sohini Das

Luxury car buyers may get 5-8% price benefit: Mercedes-Benz India MD & CEO

Mercedes-Benz India MD & CEO Santosh Iyer says GST rationalisation will boost festive sales, with buyers set to gain 5-8% price benefit

Health ministry looks to reduce drug development, approval timelines

The Union Health Ministry has proposed amendments to NDCT Rules 2019 to reduce test licence timelines from 90 to 45 days and ease approvals for BA/BE studies

Ethical marketing code: Cost of compliance may rise for drug, device firms

UCPMPD 2024 boosts transparency and ethics, but smaller firms may struggle with higher costs and reporting demands

Tariffs, costs, and shifting strategies: Indian pharma's new playbook

Analysts say Indian pharma firms will increase focus on non-US exports and the domestic market as US tariff threats persist, with firms exploring offshore manufacturing options

Tyre maker Ceat expects 10-15% revenue boost on Camso acquisition

CEAT expects a 10-15% topline boost after acquiring Michelin's Camso compact construction line in a $225 mn deal, gaining Sri Lanka plants and global brand rights

Ceat completes acquisition of Camso, to invest $171 mn in Sri Lanka

The investment is aimed at expanding manufacturing capacity for off-highway tyres (OHT) and tracks at the Midigama and Kotugoda facilities

Dealerships face inventory glut in August as car buyers await GST cuts

VAHAN data shows 3% m-o-m drop in retail auto sales; EV market hopes hold up

Maharashtra, UP lead auto sales across segments in Q1 FY26, shows SIAM data

Maharashtra and UP lead India's Q1FY26 automobile sales across passenger, two-wheeler, three-wheeler and CV segments, as per SIAM data

Front seat view: Luxury cars and bikes rev up for the festival season

Luxury carmakers are shifting into high gear with a mix of product launches, personalised experiences & lifestyle-led engagement

Festival season cheer on hold as auto buyers await GST relief and discounts

Festival offers are already running with benefits between ₹1.5 lakh and ₹2 lakh on some models

Big opportunity to grow in US market: IKS Health CFO Nithya Balasubramanian

Rakesh Jhunjhunwala-backed IKS Health sees significant opportunity in the US healthcare market, as the government pushes reforms aimed at reducing soaring healthcare costs

GST tweaks may impact electric vehicle demand, near-term car sales

Move likely to benefit smaller cars which have been under pressure

Robo-surgeries soar as AI boosts surgical efficiency, diagnostic precision

AI is adding to the efficiency of surgical procedures through predictive analytics, clinical decision support and diagnostic precision

M&M shifts gear for global next-gen SUVs, expanding capacity and sites

Looks to acquire 350 acres in Igatpuri, ramp up Chakan capacity by 240K units by FY27

Passenger vehicle despatches in reverse gear for 3rd straight month in July

PV production in July was nearly unchanged at 398,071 units (up 0.1 per cent), indicating that original equipment manufacturer despatches are being calibrated to retail demand

Mixed Q1 results for top drug firms amid price erosion, tariff threat

Fresh launches boosted growth for players like Lupin, Torrent

Metropolis Healthcare unperturbed by Amazon's diagnostics segment foray

'Amazon's entry is through a partnership with Orange Health. It is more of a distribution through Amazon'

Tata Motors Q1 results: PAT down 30.5% on JLR tariff hit, lower volumes

The Ebitda margin was down 480 basis points (bps) year-on-year (Y-o-Y) to 9.2 per cent. Ebitda stands for earnings before interest, tax, depreciation, and amortisation

Confident about Biocon's response to US tariffs: Kiran Mazumdar-Shaw

We remain confident in our global footprint and are well positioned to respond once more details are available. , said Biocon Chairperson

Pharma Inc mulls offshore strategy as US tariff fears hit sentiment

Despite current exemptions, Indian pharma firms are preparing for potential US tariffs through offshore units, EU market focus, and sourcing diversification